Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of FKB327 (Hulio) vs Humira in Rheumatoid Arthritis
NCT02260791Phase 3Completed
- Sponsor
- Fujifilm
- Start
- Dec 2014
- Primary completion
- Jul 2016
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
Phase 3, randomised, double-blind trial of adalimumab in rheumatoid arthritis (RA) (2 arms), sponsored by Fujifilm. Primary endpoint: American College of Rheumatology 20 Response Rate at 24 weeks. Started Dec 2014; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02260791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260791.